9
Ibogaine company receives $15 million from Google co-founder’s nonprofit; Could a road through federal land derail a planned psilocybin center in Oregon?; questions remain about FDA’s investigation
themicrodose.substack.com
12
Psychedelics for dogs?: 5 Questions for veterinarian Carlo Siracusa
themicrodose.substack.com
22
Your brain on psilocybin; Massachusetts to vote on psychedelic ballot initiative in November; and two new species of Psilocybe mushrooms discovered
themicrodose.substack.com
26
Kentucky’s Ibogaine Evangelist
themicrodose.substack.com
16
Should neuroscience researchers embrace religion and spirituality? Washington psychedelics ballot initiative advances; and learning from pre-1970s psychedelics researchers
themicrodose.substack.com
14
Psychedelic science comics: 5 Questions for artist and cartoonist Audra McNamee
themicrodose.substack.com
11
RAND Corporation report digs into U.S. psychedelic use; Yet another California psychedelics bill dies; The latest on Lykos and MDMA-assisted therapy
themicrodose.substack.com
13
Prescriptions for MDMA and psilocybin in Utah?: 5 Questions for Republican State Senator Kirk A. Cullimore
themicrodose.substack.com
17
Government report recommends that the DEA increase transparency for psychedelic churches, and largest study yet of at-home ketamine effects
themicrodose.substack.com
25
Acid blotter paper art: 5 Questions for author Erik Davis
themicrodose.substack.com
The Microdose
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics
The Microdose
themicrodose.substack.com